Education
About Us
Working with TipRanks
Follow Us
Tandem Diabetes Care (TNDM)
NASDAQ:TNDM
RESEARCH TOOLSreports
TNDM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$25.78 - $53.69
Previous CloseN/A
Volume336.73K
Average Volume (3M)938.55K
Market Cap
$2.04B
Enterprise Value$2.78B
Total Cash (Recent Filing)$41.83M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.45
Next Earnings
Feb 26, 2025EPS Estimate
-0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.94
Shares Outstanding65,676,530
10 Day Avg. Volume1,014,777
30 Day Avg. Volume938,550
Standard Deviation0.18
R-Squared0.15
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.38
Price to Cash Flow (P/CF)19.00
P/FCF Ratio23.60
Enterprise Value/Market Cap1.37
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.57
Enterprise Value/Ebitda-27.98
Forecast
1Y Price Target
$47.75Price Target Upside42.16% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
---
Bulls Say, Bears Say
Bulls Say
EarningsWorldwide revenue in 4Q'24 was $252.4M, up 21% year over year, which exceeded the Street’s $250.6M consensus estimate.
Market OpportunitiesT2D FDA clearance opens up massive TAM, providing multi-year tailwind to pump up the numbers.
Bears Say
US Pump SalesTNDM's stock is down 18% AH, likely in reaction to 4Q US pump sales of $98M missing the $105M estimate.
---
Ownership Overview
0.74% Insiders
33.16% Mutual Funds
0.20% Other Institutional Investors
39.90% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TNDM FAQ
What was Tandem Diabetes Care’s price range in the past 12 months?
Tandem Diabetes Care lowest stock price was $25.78 and its highest was $53.69 in the past 12 months.
What is Tandem Diabetes Care’s market cap?
Tandem Diabetes Care’s market cap is $2.04B.
When is Tandem Diabetes Care’s upcoming earnings report date?
Tandem Diabetes Care’s upcoming earnings report date is Feb 26, 2025 which is yesterday.
How were Tandem Diabetes Care’s earnings last quarter?
Tandem Diabetes Care released its earnings results on Feb 26, 2025. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.22 by $0.23.
Is Tandem Diabetes Care overvalued?
According to Wall Street analysts Tandem Diabetes Care’s price is currently Undervalued.
Does Tandem Diabetes Care pay dividends?
Tandem Diabetes Care does not currently pay dividends.
What is Tandem Diabetes Care’s EPS estimate?
Tandem Diabetes Care’s EPS estimate is -0.21.
How many shares outstanding does Tandem Diabetes Care have?
Tandem Diabetes Care has 65,676,530 shares outstanding.
What happened to Tandem Diabetes Care’s price movement after its last earnings report?
Tandem Diabetes Care reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.22. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Tandem Diabetes Care?
Currently, no hedge funds are holding shares in TNDM
---
Tandem Diabetes Care Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$47.75 (42.16% Upside)
$47.75 (42.16% Upside)
Blogger Sentiment
Bullish
TNDM Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 712.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days >0.1%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
14.45%
12-Months-Change
Fundamentals
Return on Equity
-45.96%
Trailing 12-Months
Asset Growth
1.90%
Trailing 12-Months
Company Description
Tandem Diabetes Care
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.
---
TNDM Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant achievements, including record sales, the launch of the Control-IQ+ system, and expansion into the type 2 diabetes market. However, challenges remain with U.S. sales shortfalls, potential disruptions from sales force realignment, and international transition complexities. Overall, the positive developments and strategic initiatives indicate strong growth potential, though execution risks exist.Read More>---
TNDM Revenue Breakdown
74.21% U.S.
25.79% International
---
TNDM Stock 12 Month Forecast
Average Price Target
$47.75
▲(42.16% Upside)
Technical Analysis
Best Analysts Covering TNDM
1 Year
1 Year Success Rate
21/28 ratings generated profit
1 Year Average Return
+124.43%
reiterated a buy rating 7 months ago
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +124.43% per trade.
---